Ultragenyx (RARE), Solid Biosciences (SLDB) Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for DMD

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ACN
3. NVDA
4. MU
5. GOOGL
6. USO
7. APGE
8. ABBV
9. DFTX
10. MSFT

Go back to Ultragenyx (RARE), Solid Biosciences (SLDB) Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for DMD
ULTRAGENYX PHARM (NASDAQ: RARE) Delayed: 29.03 --0 (-0%)
Previous Close $29.03    52 Week High $117.12 
Open $29.03    52 Week Low $46.52 
Day High $29.03    P/E N/A 
Day Low $29.03    EPS $-1.97 
Volume 42       

(NASDAQ: SLDB) Delayed: 8.30 --0 (-0%)
Previous Close $8.30    52 Week High $ 
Open $8.30    52 Week Low $ 
Day High $8.30    P/E N/A 
Day Low $8.30    EPS $ 
Volume 1,460